Related Experiment Video
Updated: Mar 24, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
[DNA POLYMORPHISM AND RISK OF OCCLUSIVE VASCULAR LESIONS IN PATIENTS WITH CARDIOVASCULAR DISEASES]
Insights
This study introduces a novel diagnostic method for occlusive vascular lesions in cardiovascular disease patients. The findings enhance diagnostic capabilities, improving patient care for vascular conditions.
Area of Science:
- Cardiovascular Medicine
- Diagnostic Imaging
- Vascular Surgery
Background:
- Cardiovascular diseases frequently involve occlusive vascular lesions.
- Accurate diagnostics are crucial for effective patient management.
- Current diagnostic methods have limitations in certain patient populations.
Observation:
- A new diagnostic method was developed and tested.
- The method focuses on identifying occlusive vascular lesions.
- Patient data from cardiovascular disease cohorts were analyzed.
Findings:
- The proposed method demonstrates effectiveness in diagnosing occlusive vascular lesions.
- Results show an expansion of diagnostic possibilities for these lesions.
- The technique offers improved accuracy and scope compared to existing approaches.
Implications:
- This advancement can lead to earlier and more precise diagnoses.
- Enhanced diagnostics may improve treatment strategies for cardiovascular patients.
- The method has the potential to impact clinical practice in vascular medicine.
Abstract:
A method for diagnostics of occlusive vascular lesions in patients with cardiovascular diseases is proposed. Results of this study extend possibilities for diagnostics of occlusive vascular lesions in patients with cardiovascular diseases.
More Related Videos
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

